Whole-body Electrostimulation on Functional Mobility and Quality of Life in the Elderly
NCT ID: NCT06131671
Last Updated: 2024-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-01-22
2024-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Stimulation in Older Adults
NCT06046885
Biomedical Instrumentation in the Study of Mirror Therapy in Elderly's Hands Motor Activity
NCT02104102
Strategies to Control Robotic Hand Prosthesis Via HD-sEMG and to Restore Sensory Feedback Via TENS
NCT06486571
Electrical Muscle Stimulation on Muscle Stiffness and Functional Capacity in Post-menopausal Women
NCT04276077
Neuromuscular Electrical Stimulation After Lung Transplantation
NCT03788876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
This group will receive whole-body electrical stimulation associated with exercises for upper, lower limbs and trunk for twice a week, for eight weeks, totaling 16 sessions.
Whole-body electrical stimulation
The parameters adopted for the treated group will be: symmetrical biphasic current, pulse width of 400 µs, frequency of 80 Hz, contraction time of five seconds and decreasing rest time, varying from 10 to 5 s. The intensity will be individually adjusted to the patient's maximum tolerance limit to produce visible muscle contraction.
The session time will be 15 to 20 minutes and the number of contractions will increase with each week of training.
Concomitant to the electrical stimuli, exercises will be performed for the elbow flexors and extensors, spine flexors and extensors, knee flexors and extensors, hip flexors and extensors and the calf muscles.
Control
This group will not receive any type of electrical stimulation or exercise.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole-body electrical stimulation
The parameters adopted for the treated group will be: symmetrical biphasic current, pulse width of 400 µs, frequency of 80 Hz, contraction time of five seconds and decreasing rest time, varying from 10 to 5 s. The intensity will be individually adjusted to the patient's maximum tolerance limit to produce visible muscle contraction.
The session time will be 15 to 20 minutes and the number of contractions will increase with each week of training.
Concomitant to the electrical stimuli, exercises will be performed for the elbow flexors and extensors, spine flexors and extensors, knee flexors and extensors, hip flexors and extensors and the calf muscles.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes;
* To have the ability to walk.
Exclusion Criteria
* Intolerance to electrical stimulator and/or changes in skin sensitivity;
* Skin injuries or burns where the electrodes are positioned;
* Sequelae of stroke;
* Recent acute myocardial infarction;
* Uncontrolled hypertension;
* Grade IV heart failure or decompensated;
* Unstable angina or arrhythmia;
* Peripheral vascular changes in the lower limbs such as venous thrombosis deep;
* Disabling osteoarticular or musculoskeletal disease;
* Uncontrolled diabetes;
* Cancer;
* Autoimmune disease;
* Pacemaker;
* Epilepsy;
* Hemophilia;
* Chronic obstructive pulmonary disease;
* Liver and kidney diseases;
* Grade II obesity (BMI≥35).
60 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leonhardt Ventures LLC
INDUSTRY
Federal University of Health Science of Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jociane Schardong
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Health Sciences of Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BS_Eldery
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.